Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002018299-25-000004
Filing Date
2025-05-15
Accepted
2025-05-15 19:34:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 14312
  Complete submission text file 0002018299-25-000004.txt   16040
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Subject) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92439 | Film No.: 25956560
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 8584003115
Boxer Capital Management, LLC (Filed by) CIK: 0002018299 (see all company filings)

EIN.: 990921494 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A